Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Immunotherapy and Cancer: Harnessing the Power of Diagnostic Assays

In this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.

Conquering CML: The Breakthrough Paradigm Change of Treatment-free Remission

Download this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.

The Year in CRISPRs

2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.

Emerging Technologies in Next-Gen Sequencing

RNA and sequencing technologies have the potential to unlock the mystery of our every dynamic transcriptome.
Scroll Up